期刊
CELLULAR AND MOLECULAR NEUROBIOLOGY
卷 -, 期 -, 页码 -出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10571-022-01200-z
关键词
MicroRNA-155; Neurodegenerative diseases; Epilepsy; Brain malignancies; Stroke; RNA therapeutics
资金
- Mashhad University of medical sciences
- IRCCS Istituto Ortopedico Galeazzi
Neuroinflammation is crucial in neurological disorder development, and miR-155 is associated with susceptibility to inflammatory and neurodegenerative diseases. It damages the CNS by enhancing pro-inflammatory cytokine expression and disrupting the blood-brain barrier.
Neuroinflammation plays a crucial role in the development and progression of neurological disorders. MicroRNA-155 (miR-155), a miR is known to play in inflammatory responses, is associated with susceptibility to inflammatory neurological disorders and neurodegeneration, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis as well as epilepsy, stroke, and brain malignancies. MiR-155 damages the central nervous system (CNS) by enhancing the expression of pro-inflammatory cytokines, like IL-1 beta, IL-6, TNF-alpha, and IRF3. It also disturbs the blood-brain barrier by decreasing junctional complex molecules such as claudin-1, annexin-2, syntenin-1, and dedicator of cytokinesis 1 (DOCK-1), a hallmark of many neurological disorders. This review discusses the molecular pathways which involve miR-155 as a critical component in the progression of neurological disorders, representing miR-155 as a viable therapeutic target.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据